Connor, Clark & Lunn Investment Management (CC&L)
NPSP

Connor, Clark & Lunn Investment Management (CC&L)’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-95,900
Closed -$3.17M – 719
2014
Q1 		$3.17M Buy
95,900
+46,500
+94% +$1.6M 0.02% 217
2013
Q4 		$1.59M Buy
49,400
+36,000
+269% +$991K 0.01% 294
2013
Q3 		$438K Buy
+13,400
New +$307K ﹤0.01% 384

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s NPSP Position: Q2 2014 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of NPS PHARMACEUTICALS INC (NPSP) in Q2 2014, closing a stake of 95,900 shares — an estimated $3.17M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in NPSP in Q3 2013 and held it in 3 quarters. The position peaked at $3.17M in Q1 2014. 215 funds tracked by Wall St. Rank hold NPSP as of Q2 2014.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining NPS PHARMACEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 95,900 NPS PHARMACEUTICALS INC shares in Q2 2014, an estimated $3.17M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in NPS PHARMACEUTICALS INC in Q3 2013 and held it in 3 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s NPS PHARMACEUTICALS INC position peaked at $3.17M in Q1 2014.
  • 215 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q2 2014.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2014, filed 14 Aug 2014.